Cargando…
A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactions
Severe infusion reactions (SIRs) at rates of 5% or less are known side effects of biological agents, including mAbs such as cetuximab. There are currently no prospectively validated risk factors to aid physicians in identifying patients who may be at risk of experiencing an SIR following administrat...
Autores principales: | Maier, Sabine, Chung, Christine H, Morse, Michael, Platts-Mills, Thomas, Townes, Leigh, Mukhopadhyay, Pralay, Bhagavatheeswaran, Prabhu, Racenberg, Jan, Trifan, Ovidiu C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312116/ https://www.ncbi.nlm.nih.gov/pubmed/25296628 http://dx.doi.org/10.1002/cam4.333 |
Ejemplares similares
-
A novel approach to predict cetuximab‐induced hypersensitivity reaction: detection of drug‐specific IgE on basophils
por: Iwamoto, Takuya, et al.
Publicado: (2016) -
IgE, α-Gal and atherosclerosis
por: Wilson, Jeffrey M., et al.
Publicado: (2019) -
IgE Production to α-Gal Is Accompanied by Elevated Levels of Specific IgG1 Antibodies and Low Amounts of IgE to Blood Group B
por: Rispens, Theo, et al.
Publicado: (2013) -
The use of machine learning to understand the relationship between IgE to specific allergens and asthma
por: Platts-Mills, Thomas A. E., et al.
Publicado: (2018) -
Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth
por: Hayes, Mark David, et al.
Publicado: (2020)